HF 2685

as introduced - 83rd Legislature (2003 - 2004) Posted on 12/15/2009 12:00am

  1.1                          A bill for an act 
  1.2             relating to insurance; extending insurance coverage to 
  1.3             include surveillance tests for ovarian cancer for 
  1.4             women at risk for ovarian cancer; amending Minnesota 
  1.5             Statutes 2002, section 62A.30, subdivision 2, by 
  1.6             adding a subdivision. 
  1.7   BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA: 
  1.8      Section 1.  Minnesota Statutes 2002, section 62A.30, 
  1.9   subdivision 2, is amended to read: 
  1.10     Subd. 2.  [REQUIRED COVERAGE.] Every policy, plan, 
  1.11  certificate, or contract referred to in subdivision 1 issued or 
  1.12  renewed after August 1, 1988, that provides coverage to a 
  1.13  Minnesota resident must provide coverage for routine screening 
  1.14  procedures for cancer, including mammograms, surveillance tests 
  1.15  for ovarian cancer for women who are at risk for ovarian cancer 
  1.16  as defined in subdivision 3, and pap smears, when ordered or 
  1.17  provided by a physician in accordance with the standard practice 
  1.18  of medicine. 
  1.19     Sec. 2.  Minnesota Statutes 2002, section 62A.30, is 
  1.20  amended by adding a subdivision to read: 
  1.21     Subd. 3.  [OVARIAN CANCER SURVEILLANCE TESTS.] For purposes 
  1.22  of subdivision 2: 
  1.23     (a) "At risk for ovarian cancer" means: 
  1.24     (1) having a family history: 
  1.25     (i) with one or more first or second-degree relatives with 
  1.26  ovarian cancer; 
  2.1      (ii) of clusters of women relatives with breast cancer; or 
  2.2      (iii) of nonpolyposis colorectal cancer; or 
  2.3      (2) testing positive for BRCA1 or BRCA2 mutations. 
  2.4      (b) "Surveillance tests for ovarian cancer" means annual 
  2.5   screening using: 
  2.6      (1) CA-125 serum tumor marker testing; 
  2.7      (2) transvaginal ultrasound; 
  2.8      (3) pelvic examination; or 
  2.9      (4) other proven ovarian cancer screening tests currently 
  2.10  being evaluated by the federal Food and Drug Administration or 
  2.11  by the National Cancer Institute.  
  2.12     Sec. 3.  [EFFECTIVE DATE.] 
  2.13     Sections 1 and 2 are effective August 1, 2004, and apply to 
  2.14  coverage issued or renewed to provide coverage to Minnesota 
  2.15  residents on or after that date.